OptimizeRx (NASDAQ:OPRX – Get Rating) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, May 10th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
OptimizeRx Price Performance
NASDAQ:OPRX opened at $14.48 on Monday. The business’s fifty day moving average price is $14.75 and its 200 day moving average price is $16.82. OptimizeRx has a 12 month low of $12.20 and a 12 month high of $30.82.
Wall Street Analysts Forecast Growth
OPRX has been the topic of several research reports. Royal Bank of Canada dropped their price objective on OptimizeRx from $22.00 to $18.00 and set an “outperform” rating on the stock in a report on Thursday, March 9th. Roth Capital reaffirmed a “buy” rating on shares of OptimizeRx in a report on Thursday, March 9th. Lake Street Capital dropped their price objective on OptimizeRx from $25.00 to $18.00 in a report on Thursday, March 9th. William Blair reaffirmed an “outperform” rating on shares of OptimizeRx in a report on Tuesday, March 21st. Finally, SVB Leerink reissued an “outperform” rating on shares of OptimizeRx in a report on Friday, January 27th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $21.00.
Institutional Investors Weigh In On OptimizeRx
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support.
- Get a free copy of the StockNews.com research report on OptimizeRx (OPRX)
- MarketBeat Week in Review – 5/1 – 5/5
- It’s Time To Check Into Booking.Com
- Shopify Delivers Growth And Efficiency; Shares Surge
- Advanced Micro Devices Bullish Reversal Is Still In Play
- Broadcom Shares Trade In Tight Range Ahead Of Q2 Earnings Report
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.